Khalifa Kush Enters Australia medical cannabis Market
Khalifa Kush enters Australia medical cannabis market. Launching premium flower and edibles via pharmacies and clinics across 6 states and 2 territories.
Tag: Australia
Australia May Impose Tariffs on Canadian Cannabis Imports
Australia’s medical cannabis market is experiencing rapid growth, with projected revenues increasing from approximately $600 million in 2024 to over…
Australians turn to medicinal cannabis for chronic pain relief
The use of medicinal cannabis in Australia is on the rise, with a significant number of prescriptions being issued for…
Australian Medical Association calls for stricter cannabis rules
The Australian Medical Association (AMA) advocates for stricter regulations on the Special Access Scheme (SAS) and Authorised Prescriber Scheme (APS)…
Curaleaf launches medical cannabis products in Australia
Curaleaf International, a subsidiary of Curaleaf Holdings Inc. (TSX:CURA), has announced the launch of its Curaleaf-branded medical cannabis products in…
Curaleaf launches medical cannabis products in Australia
Curaleaf International, a division of Curaleaf Holdings, Inc. (TSX: CURA), has announced the launch of its medical cannabis products in…
Curaleaf International launches medical cannabis products in Australia
Curaleaf International has entered the Australian medical cannabis market by launching its range of products in collaboration with Canngea. This…
Curaleaf launches new medical cannabis products in Australia
Curaleaf International, a subsidiary of Curaleaf Holdings, Inc. (TSX:CURA), has introduced a new line of medical cannabis products in Australia.…
Curaleaf launches medical cannabis products in Australia
Curaleaf International, a subsidiary of Curaleaf Holdings, Inc. (TSX:CURA), has officially introduced its Curaleaf-branded medical cannabis products in Australia. This…